Intermediate- to long-term outcomes of endoscopic transpapillary gallbladder stenting in patients with gallstone-related disease: a 10-year single-center experience.
Endoscopy
; 55(5): 469-475, 2023 05.
Article
em En
| MEDLINE
| ID: mdl-36257577
ABSTRACT
BACKGROUND:
Endoscopic transpapillary gallbladder stenting (ETGS) can be a bridging therapy to elective cholecystectomy or a permanent gallbladder drainage method in patients with symptomatic gallbladder disease who are awaiting cholecystectomy or are unfit for surgery, respectively. We evaluated the intermediate- to long-term outcomes of ETGS in these groups.METHODS:
We retrospectively reviewed 234 patients (acute cholecystitisâ=â147), who were unfit for surgery (nâ=â50) or had deferred cholecystectomy (nâ=â184) and who underwent ETGS between 2012 and 2021.âA 7-Fr, 15-cm, double-pigtail plastic stent was placed for ETGS without scheduled stent exchange. Biliary event-free rates (i.âe. cholecystitis and cholangitis) were determined at 6 months, 1 year, and ≥â2 years.RESULTS:
Technical and clinical success rates were 84.6â% (198/234) and 97.4â% (193/198), respectively. Kaplan-Meier analysis (nâ=â193) showed a biliary event-free rate of 99â% (95â%CI 0.95-1.00) at 6 months, 92â% (95â%CI 0.87-0.97) at 1 year, and 76â% (95â%CI 0.65-0.93) at ≥â2 years, during a median follow-up period of 564 days (range 200-3001 days).CONCLUSIONS:
ETGS is an effective biliary drainage method that should be considered in selected cases with common bile duct stone where cholecystectomy could not be performed or was deferred. The biliary event-free rates of ≥â76â% up to ≥â2 years further support the use of ETGS in these patient groups.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Cálculos Biliares
/
Colecistite Aguda
Limite:
Humans
Idioma:
En
Revista:
Endoscopy
Ano de publicação:
2023
Tipo de documento:
Article
País de afiliação:
Tailândia